Correction: WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome

Antzeko izenburuak

• Correction: WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
  nork: Zwi N. Berneman, et al.
  Argitaratua: (2025-03-01)
• Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion
  nork: Heleen H. Van Acker, et al.
  Argitaratua: (2018-04-01)
• Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
  nork: Heleen H. Van Acker, et al.
  Argitaratua: (2016-09-01)
• Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner.
  nork: Sébastien Anguille, et al.
  Argitaratua: (2015-01-01)
• Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands
  nork: Maarten Versteven, et al.
  Argitaratua: (2022-02-01)